Blurbs

Stryker (SYK) Receives a Buy from Leerink Partners

Leerink Partners analyst Danielle Antalffy maintained a Buy rating on Stryker (SYKResearch Report) on January 24 and set a price target of $300.00. The company’s shares closed last Thursday at $255.44.

According to TipRanks.com, Antalffy is a 4-star analyst with an average return of 9.1% and a 52.0% success rate. Antalffy covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Treace Medical Concepts.

Currently, the analyst consensus on Stryker is a Moderate Buy with an average price target of $285.00, implying an 11.5% upside from current levels. In a report issued on January 28, UBS also maintained a Buy rating on the stock with a $267.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $281.16 and a one-year low of $227.84. Currently, Stryker has an average volume of 1.37M.

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SYK in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.

Read More on SYK:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos